Medicare billing address
CMS Medicare provider billing file
417 Quarry Lakes DrSandusky, OH 44870
CMS public data · NPI 1104265156
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Adarsh Vennepureddy, M.D
Specialty
Credential
M.D
NPI
1104265156
Primary source state
OH
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Adarsh Vennepureddy, M.D from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
417 Quarry Lakes DrCMS Doctors & Clinicians file
9500 Euclid AveIn the 2024 CMS provider billing file, this NPI had 360 Medicare beneficiaries and 16,026 total services. The average beneficiary age was 74, and the average HCC risk score was 2.1.
Total Medicare allowed amount
$338,791.86
Total Medicare payment amount
$268,282.45
Medicare beneficiaries
360
Total services
16,026
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
37%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Chronic kidney disease
31%
CMS beneficiary-panel share
Anxiety
30%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, ferric derisomaltose, 10 mg | 1,200 | $20.68 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 193 | $91.78 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 114 | $62.36 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 71 | $114.18 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 60 | $15.67 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 55 | $80.60 |
| Injection of additional new drug or substance into vein | 45 | $14.06 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 41 | $74.46 |
| Injection of drug or substance under skin or into muscle | 27 | $13.36 |
| New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | 26 | $203.59 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1104265156. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Eliquis | Apixaban | 179 | 253.8 | $143,133.15 |
| 2 | Prednisone | Prednisone | 95 | 95 | $322.52 |
| 3 | Dexamethasone | Dexamethasone | 82 | 94.3 | $1,166.65 |
| 4 | Hydroxyurea | Hydroxyurea | 81 | 131 | $1,706.83 |
| 5 | Potassium Chloride | Potassium Chloride | 64 | 66.5 | $1,425.32 |
| 6 | Abiraterone Acetate | Abiraterone Acetate | 59 | 59 | $82,101.37 |
| 7 | Xtandi | Enzalutamide | 59 | 59 | $680,662.38 |
| 8 | Ondansetron Hcl | Ondansetron Hcl | 55 | 59 | $4,397.70 |
| 9 | Xarelto | Rivaroxaban | 54 | 105.2 | $57,963.18 |
| 10 | Acyclovir | Acyclovir | 40 | 52 | $259.29 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2012
Group/practice field
Cleveland Clinic
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.